Antifungal Chemoprophylaxis after Blood and Marrow Transplantation

This publication has 26 references indexed in Scilit:

• Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
  Blood, 2000
• Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy
  Clinical Infectious Diseases, 1999
• Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia
  New England Journal of Medicine, 1998
• Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study
  The Journal of Infectious Diseases, 1995
• Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow Transplantation
  New England Journal of Medicine, 1992
• Empiric antifungal therapy in febrile granulocytopenic patients
  The American Journal of Medicine, 1989
• An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis
  The American Journal of Medicine, 1988
• Prevention of fungal sepsis in patients with prolonged neutropenia: A randomized, double-blind, placebo-controlled trial of intravenous miconazole
  The American Journal of Medicine, 1987
• Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
  The American Journal of Medicine, 1982